Search - tctmd.com

Displaying 361 - 380 of 470

Sort: Relevancy | Date

Presentation TCT 2013

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Presenter: Edith Lubos

October 29, 2013

Presentation TCT 2013

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

Presenter: Anita Asgar

October 29, 2013

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

MitraClip: Utility in Functional Mitral Regurgitation

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Presenter: Blase Carabello

October 28, 2013

Presentation TCT 2013

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Presenter: Alec Vahanian

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Presenter: Dominique Himbert

October 28, 2013

Presentation TCT 2013

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Presenter: Robert Bonow

October 28, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Presenter: Tim Lapp

October 27, 2013

Presentation TCT 2013

Mitral Regurgitation

Presenter: John Webb

October 27, 2013

News Daily News

MitraClip Gains FDA Approval for Nonsurgical Patients

October 25, 2013

News Industry News

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

October 25, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

Presentation

Interplay Between Mitral Regurgitation and TAVR with CoreValve

Presenter: F. Bedogni

October 07, 2013

News Daily News

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

L.A. McKeown

September 20, 2013

Advertisement

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

MitraClip: Utility in Functional Mitral Regurgitation

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Mitral Regurgitation

MitraClip Gains FDA Approval for Nonsurgical Patients

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Interplay Between Mitral Regurgitation and TAVR with CoreValve

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content